Smart Medical Dressing: The Future of Bespoke Healing

Outlined in Nature Materials, the advanced biomaterial uses aptamer constructs to selectively harvest and concentrate endogenous healing substances, offering a potential breakthrough for patients with acute and chronic wounds that fail to heal on their own.

How Biomaterial Scaffolds Target Chronic Wounds

Millions of people worldwide suffer from hard-to-heal wounds like large burns, diabetic foot ulcers, and non-union fractures. These difficult injuries cause severe pain, increase infection risks, and often demand extensive clinical interventions, according to the research team. Traditional wound care relies on sprays and creams containing high doses of manufactured growth factors. By contrast, the novel dressing attaches aptamer constructs to biomaterial scaffolds to capture biological substances already produced by the patient’s body.

These endogenous growth factors remain completely inactive within the material until specific physical conditions occur. When a patient’s cells exert traction forces on the dressing during the natural healing process, the material releases the biological therapy exactly at the optimal time and place. This mechanism prevents the rapid degradation often seen in conventional topical treatments and uses far lower doses overall.

Testing and Biological Integration in Human Tissues

Lead researcher Magdalene Ho, PhD, from Imperial College London, noted the significance of testing the material on actual human tissue. “What excites me most is that this works in living human skin,” Ho said, adding that researchers observed repair cells actively migrating into the dressing to engage with human biology.

Preclinical tests demonstrated clear therapeutic benefits across multiple models. According to the study findings, the dressing promoted vascularization in a rat femur injury model and reduced wound diameter in mouse skin models. Furthermore, tests on ex vivo human skin wound models—obtained from women undergoing abdominoplasty—showed healing advantages.

Future Clinical Translation and Biomaterial Portfolios

The research team reported that their study establishes cellular traction forces as a viable trigger for controlled therapeutic delivery across diverse species and tissues. Because a substantial global aptamer portfolio and existing knowledge base already exist, scientists anticipate a foundation for rapid development. These cell-responsive biomaterials could soon deliver defined biologic therapies across a wide range of clinical indications, moving the technology closer to hospital clinics.

Frequently Asked Questions

How does the medical dressing deliver growth factors?

The dressing uses aptamer constructs attached to biomaterial scaffolds that harvest and concentrate the body’s own growth factors. These substances are safely held until mechanical traction forces from healing cells trigger their precise release.

What types of wounds can this technology treat?

Researchers designed the material to target acute and chronic wounds that struggle to heal independently, including diabetic foot ulcers, severe burns, and non-union bone fractures.

When will this wound dressing be available in clinics?

While laboratory tests on human skin models and animal studies show promising results, the technology requires further clinical trials before gaining regulatory approval for widespread patient care.